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rophic factor deprivation (TFD)-induced apoptosis
in sympathetic neurons requires macromolecular
synthesis–dependent BAX translocation, cytochrome
 
c
 
 (cyt 
 
c
 
) release, and caspase activation. Here, we report
the contributions of other intrinsic and extrinsic pathway
signals to these processes. Sympathetic neurons expressed
all antiapoptotic BCL-2 proteins examined, yet expressed
only certain BH3-only and multidomain proapoptotic BCL-2
family members. All coexpressed proapoptotic proteins did
not, however, exhibit functional redundancy or compensatory
expression, at least in the 
 
Bax
 
 
 
/
 
 
 
, 
 
Bak
 
 
 
/
 
 
 
, 
 
Bim
 
 
 
/
 
 
 
, 
 
Bid
 
 
 
/
 
 
 
,
and 
 
Bad
 
 
 
/
 
 
 
 neurons examined. Although the subcellular
distribution or posttranslational modiﬁcation of certain
BCL-2 proteins changed with TFD, neither transcriptional
T
 
nor posttranslational mechanisms regulated the expression
or subcellular localization of BID, BAD, or BAK in this
paradigm. Despite modest induction of 
 
Fas
 
 and 
 
FasL
 
 ex-
pression, Fas-mediated signaling did not contribute to
TFD-induced apoptosis in sympathetic neurons. Similar
ﬁndings were obtained with K
 
 
 
 withdrawal–induced
apoptosis in cerebellar granule neurons, a model for activity-
dependent neuronal survival in the CNS. Thus, expression
alone does not guarantee functional redundancy (or
compensation) among BCL-2 family members, and, at least
in some cells, extrinsic pathway signaling and certain
BH3-only proteins (i.e., BID and BAD) do not contribute to
BAX-dependent cyt 
 
c
 
 release or apoptosis caused by TFD.
 
Introduction
 
In mammals, signaling cascades culminating in apoptotic
cell death can be divided into two broad categories: the
“intrinsic” (i.e., apoptosome) and the “extrinsic” (i.e., death
receptor and perforin/granzyme) pathways. Current evidence
suggests the following model for activation of the intrinsic
pathway of apoptosis. A death signal induces the release of
mitochondrial proteins, such as cytochrome 
 
c
 
 (cyt 
 
c
 
)* (Liu et
al., 1996) and Smac/Diablo (Du et al., 2000; Verhagen et
al., 2000), through an unknown mechanism that may involve
a pore formed by proapoptotic BCL-2 family proteins and/
or the permeability transition pore. Once released, Smac/
Diablo releases inhibitor-of-apoptosis protein–mediated
inhibition of procaspases, whereas cyt 
 
c
 
 forms a complex
with Apaf-1 and procaspase-9, which in the presence of ATP
or dATP, becomes activated, resulting in further caspase
activation, cleavage of cellular substrates, and cell death (Liu
et al., 1996; Li et al., 1997; Zou et al., 1997).
In contrast, so-called “extrinsic” pathway signals, such as
those mediated by death receptors of the TNF receptor
superfamily, activate the caspase cascade more directly. For
example, interaction of Fas with its ligand (FasL) triggers
formation of a death-inducing signaling complex (DISC)
that includes the critical adaptor molecule FADD, which in
turn recruits procaspase-8. According to the induced–proximity
model (Salvesen and Dixit, 1999), procaspase-8 undergoes
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autoproteolytic cleavage, forming active caspase-8, which in
turn can activate other procaspases, culminating in cleavage
of cellular substrates, and apoptosis.
Crosstalk between the intrinsic and extrinsic pathways can
occur. For example, activation of caspase-8 through Fas in-
duces cleavage of full-length (p22) BID. The COOH-termi-
nal p15 tBID fragment then translocates to mitochondria,
where it causes (either directly or indirectly) cyt 
 
c
 
 release, re-
sulting in apoptosome formation, caspase activation, and
cell death (Li et al., 1998; Luo et al., 1998).
Regulation of the activities of BCL-2 proteins is complex
and includes both transcriptional (e.g., EGL-1, BIM, and
HRK) and posttranslational (e.g., BAD, BID, BAX) mecha-
nisms. In the case of the multidomain proapoptotic protein
BAX, a critical regulatory mechanism is subcellular compart-
mentalization. Apoptotic stimuli result in the translocation
of BAX from the cytosol to mitochondria, leading to multi-
merization, integration, and cyt 
 
c
 
 release, culminating in cas-
pase activation and apoptosis. However, the mechanisms re-
sponsible for triggering these events remain poorly defined.
The regulation of BAX function has been studied exten-
sively in the context of trophic factor deprivation (TFD)-
induced apoptosis in neonatal sympathetic neurons, an in
vitro paradigm that recapitulates the physiological cell death
that these cells undergo in vivo during development. Apop-
tosis in this model requires de novo protein synthesis (Mar-
tin et al., 1988) and caspase activation (Deshmukh et al.,
1996; Troy et al., 1996; McCarthy et al., 1997). Most im-
portant, in contrast to other paradigms in which the regula-
tion of BAX has been examined, sympathetic neurons abso-
lutely require endogenous BAX expression (Deckwerth et
al., 1996; Deshmukh and Johnson, 1998) and translocation
(Putcha et al., 1999, 2000) for cyt 
 
c
 
 release, caspase activa-
tion, and apoptosis.
Multidomain proapoptotic BCL-2 family members such
as BAX and BAK may serve redundant functions in the reg-
ulation of cell death (Lindsten et al., 2000; Wei et al., 2001).
Such redundancy may be true not only for multidomain
proapoptotic BCL-2 proteins, but also for members of the
BH3-only subfamily. For example, targeted deletion of
BIM, a BH3-only protein induced during TFD in sympa-
thetic neurons, confers partial protection against cyt 
 
c
 
 release
and apoptosis (Putcha et al., 2001), consistent with func-
tional compensation by another BH3-only protein, HRK,
which is also induced with similar kinetics in this paradigm
(Imaizumi et al., 1997). Therefore, reproduction of the phe-
notype seen in 
 
Bax
 
 
 
/
 
 
 
 mice, in which cyt 
 
c
 
 release and apop-
totic cell death are completely prevented in many neurons,
may require inactivation of at least both BIM and HRK. Be-
cause both proapoptotic and antiapoptotic BCL-2 proteins
often exhibit overlapping spatial and temporal expression
patterns, these findings suggest that functional redundancy
among BCL-2 family members may be a common theme in
the regulation of cell death.
Here, we report that neonatal sympathetic neurons ex-
pressed all antiapoptotic BCL-2 proteins examined and sev-
eral multidomain and BH3-only proapoptotic BCL-2 family
members. However, targeted deletion of only certain pro-
teins (i.e., BAX or BIM) inhibited TFD-induced cyt 
 
c
 
 re-
lease and cell death. Moreover, neither transcriptional nor
posttranslational mechanisms appeared to regulate the ex-
pression and subcellular distribution of several pro- and an-
tiapoptotic BCL-2 proteins in this paradigm. Finally, al-
though NGF deprivation induced 
 
Fas
 
 and 
 
FasL
 
 expression,
analysis of 
 
lpr
 
 and 
 
gld
 
 mice indicates that Fas/FasL signaling
did not contribute to TFD-induced apoptosis in these neu-
rons. Similar results were obtained with K
 
 
 
 withdrawal in
cerebellar granule neurons (CGNs), a model of activity-
dependent neuronal survival in the CNS.
Taken together, these observations indicate the following.
First, expression alone did not guarantee functional redun-
dancy or compensation among proapoptotic BCL-2 family
members. Second, neither BID nor BAD contributed to
BAX-dependent cyt 
 
c
 
 release and its downstream sequelae in
these paradigms. And finally, extrinsic pathway signaling
had little, if any, role in TFD-induced neuronal apoptosis.
 
Results
 
Expression of BCL-2 family members 
during neuronal apoptosis
 
BCL-2 proteins regulate programmed cell death (PCD) in
two well-characterized models of neuronal apoptosis: NGF
deprivation in superior cervical ganglion (SCG) neurons (a
PNS population) and K
 
 
 
 withdrawal in CGNs (a CNS pop-
ulation).
To study the regulation of TFD-induced apoptosis by
other pro- and antiapoptotic BCL-2 family members, we ex-
amined their expression during NGF deprivation in SCG
neurons (Fig. 1 A) and K
 
 
 
 withdrawal in CGNs (Fig. 1 B).
For SCG neurons, these experiments were conducted in the
presence of the broad-spectrum caspase inhibitor, BAF; for
CGNs, the studies were done with neurons from 
 
Bax
 
 
 
/
 
 
 
mice. In both cases, these experimental conditions were cho-
sen to allow “early” signaling events genetically upstream of
the BAX/BCL-2 and caspase checkpoints to occur, while
preventing cell death. In contrast to BIM, which was signifi-
cantly induced during cell death in both paradigms, expres-
sion of the multidomain proteins BAK, BAX, BCL-2, BCL-
X
 
L
 
, and BCL-w and the BH3-only proteins BID and BAD
did not change significantly during the first 24 h after depri-
vation. At later time points (e.g., 72 h), expression of these
proteins, like that of all proteins, declined.
With respect to the aforementioned findings, several
points warrant mention. First, we observed neither loss of
full-length (p22) BID nor appearance of truncated (p15)
BID (tBID), suggesting that activation of the extrinsic path-
way leading to caspase-8–dependent cleavage of BID is not
critical to cell death in either model. Second, RT-PCR anal-
ysis indicated that both SCG and CG neurons express sev-
eral other known antiapoptotic members (e.g., 
 
Mcl-1
 
 and
 
Bfl-1/A1
 
), but only express a select repertoire of proapop-
totic proteins, both multidomain and BH3-only. For exam-
ple, neither neuronal population showed detectable expres-
sion of either 
 
Bok
 
 or 
 
Bik
 
 mRNA (unpublished data). Third,
although we observed changes in the migration of BAD con-
sistent with trophic factor–dependent phosphorylation of
BAD (Figs. 1 and 2; and unpublished data), our efforts to 
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examine changes in the phosphorylation status of BAD asso-
ciated with cell death in both SCG and CG neurons were
hindered by the poor reactivity and specificity of commer-
cially available phosphospecific antibodies (see Materials and
methods). Finally, neither 
 
Bax
 
 deletion nor caspase inhibi-
tion inhibited c-Jun phosphorylation, an indicator of JNK
activation, in these paradigms (Fig. 1; Miller et al., 1997;
Deckwerth et al., 1998). However, 
 
Bax
 
 deletion, but not
caspase inhibition, prevented the loss of mitochondrial cyt 
 
c
 
.
Therefore, like SCG neurons (Deshmukh and Johnson,
1998; Putcha et al., 2000), CGNs require BAX for cyt 
 
c
 
 re-
lease (Fig. 1) and cell death (Miller et al., 1997).
Finally, Sun et al. (2001) recently reported that SCG neu-
rons express 
 
N-Bak
 
, a BH3-only splice variant of 
 
Bak
 
, but not
full-length 
 
Bak
 
, which they suggest is expressed only by the
nonneuronal cells in SCG cultures, which represent 
 
 
 
5% of
the cells present in these cultures. In light of this report and
the phenotype of 
 
Bak
 
 
 
/
 
 
 
 neurons, we evaluated whether the
BAK expression observed in cultures of SCG and CG neurons
derived solely from nonneuronal cells by examining expres-
sion in the presence and absence of antimitotic agents (Fig. 1,
C and D, respectively). We chose immunoblotting over im-
munocytochemistry because no BAK antibodies we tested
were specific for the latter application, whereas at least one
was specific for the former (see Materials and methods). As
shown in Fig. 1, C and D, CG, but not SCG, neurons express
BAK; neither appears to express N-BAK (unpublished data).
Both neuronal populations express BAD, BID, and BAX (Fig.
1, C and D). Therefore, for the remainder of the paper, “SCG
or CG neurons” will designate SCG or CG neuronal cultures
(containing no more than 5% nonneuronal cells).
In sum, both SCG and CG neurons selectively express multi-
ple members of all three subfamilies of BCL-2 proteins. How-
ever, like EGL-1 in nematodes (Conradt and Horvitz, 1998),
only BH3-only proteins, such as BIM and HRK, are induced
during TFD in these neurons. Intriguingly, the BCL-2 family
expression patterns of SCG and CG neurons, as well as their
dependence on particular family members (e.g., BAX and BIM)
for TFD-induced apoptosis, are remarkably concordant.
 
Subcellular distribution of multidomain and BH3-only 
BCL-2 family members during neuronal apoptosis
 
The sequestration of cell death effectors, such as BAX and
cyt 
 
c
 
, within distinct subcellular compartments has recently
emerged as a common theme in the regulation of apoptosis.
Therefore, we examined the localization of endogenous
BCL-2, BCL-X
 
L
 
, BCL-w, BAD, BID, and BAK by using
subcellular fractionation. As shown in Fig. 2, BCL-2 and
BAK were found exclusively in the heavy membrane fraction
enriched in mitochondria; BCL-X
 
L
 
 and BCL-w localized to
both the cytosolic and mitochondrial fractions; BAD and
BID were found exclusively in the cytosolic fraction. With
NGF deprivation, we observed loss of the cytosolic pools of
BCL-X
 
L
 
 and BCL-w, raising the possibility that selective
degradation of these proteins may contribute to the translo-
cation of BAX required for TFD-induced neuronal apopto-
sis (see Discussion). Furthermore, consistent with the find-
ings shown in Fig. 1 A, we did not observe loss of p22 BID
Figure 1. Expression profile of pro- and antiapoptotic BCL-2 family 
proteins during neuronal apoptosis. (A) SCG neurons (5 d in vitro, 
DIV5) were maintained in NGF or deprived of NGF in the presence 
of 50  M BAF for the indicated times and then lysed. Expression of 
proteins was analyzed by immunoblotting. See Materials and 
methods for verification of antibody specificity. Tubulin immuno-
blotting confirmed equal protein loading. (B) DIV7 CGNs from Bax
–/– 
mice were maintained in K25 S or in K5 S for various periods. At 
the indicated times, whole cell extracts were prepared and analyzed 
by Western blotting. (C) Neonatal rat SCG neurons were plated in 
NGF (lanes 1–4) or in  NGF (lanes 5 and 6) in the presence (lanes 
2, 4, and 6) or absence (lanes 1, 3, and 5) of aphidicolin (Aph). At DIV5, the neurons were maintained in NGF (lanes 1 and 2) or deprived of 
NGF (lanes 3–6) in the presence (lanes 2, 4, and 6) or absence (lanes 1, 3, and 5) of aphidicolin (Aph). All cells were lysed 96 h later (DIV9), 
and expression of proteins was analyzed by immunoblotting. Tubulin immunoblotting tracked neuronal survival. Fluorodeoxyuridine was 
present in all cultures. (D) P7 rat CGNs were plated in K25 S (lanes 1–4) or in K5 S (lanes 5 and 6). Aph was added to some cultures (lanes 
2, 4, and 6) 24–36 h later. At DIV7, the neurons were switched to K25 S (lanes 1 and 2) or K5 S (lanes 3–6) in the presence (lanes 2, 4, and 
6) or absence (lanes 1, 3, and 5) of Aph. All cells were lysed 96 h later (DIV11), and expression of proteins was analyzed by immunoblotting. 
Neuron-specific enolase (NSE) immunoblotting tracked neuronal survival. 
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or appearance of p15 tBID in either the cytosolic or mito-
chondrial fractions, suggesting that BID was not cleaved,
nor did BID or tBID translocate to mitochondria, during
NGF deprivation in SCG neurons. Finally, the cytosolic lo-
calization of BAD did not change during TFD (unpublished
data).
To determine whether BCL-2 proteins associated with
mitochondria were integrated into mitochondrial mem-
branes, we performed alkali extraction of the mitochondrial
fractions from NGF-maintained and -deprived SCG neu-
rons. In this assay, mitochondrial integral membrane pro-
teins are resistant to extraction by 0.2 M Na
 
2
 
CO
 
3
 
, yet sensi-
tive to extraction by 1% SDS, whereas peripheral membrane
proteins are extracted by both treatments. Using this assay,
we previously demonstrated that, after induction or translo-
cation from the cytosol to mitochondria, BIM and BAX, re-
spectively, integrate into the mitochondrial outer membrane
(Putcha et al., 2000, 2001). Similar analyses indicated that
mitochondrial BAK, BCL-2, BCL-w, and BCL-X
 
L
 
 were in-
tegral membrane proteins in mitochondria (Fig. 2).
 
Fas-mediated extrinsic pathway signaling does not 
contribute to TFD-induced neuronal apoptosis
 
Extrinsic pathway signaling through death receptors, such as
Fas, is critical for cellular homeostasis in the immune system
in response to both physiological and pathological cues. Re-
cently, several groups suggested that Fas/FasL signaling con-
tributes to cell death during development and/or in response
to apoptotic stimuli, such as TFD (Brunet et al., 1999; Le-
Niculescu et al., 1999; Raoul et al., 1999), chemotherapeu-
tic agents (Friesen et al., 1996), or ischemia (Martin-Villalba
et al., 1999). Since these stimuli generally require macromo-
lecular synthesis for complete and efficient neuronal cell
death (Martin et al., 1988; D’Mello et al., 1993; Miller and
Johnson, 1996), the groups proposed that cell death in these
models requires transactivation of Fas and FasL, presumably
followed by cell autonomous and noncell autonomous Fas-
dependent apoptosis. However, other reports cast doubt on
this hypothesis (Eischen et al., 1997; Gerhardt et al., 2001).
To study the contribution of Fas–FasL interactions to
neuronal apoptosis in SCG neurons, we first examined
mRNA expression of 
 
Fas
 
 and 
 
FasL
 
 during TFD. As shown
in Fig. 3 A, NGF withdrawal induced a modest (
 
 
 
2-fold)
elevation in 
 
Fas
 
 and 
 
FasL
 
 during TFD. Similarly, induction
of 
 
Fas
 
 and 
 
FasL
 
 occurs during cell death caused by cytosine
arabinoside (AraC) in sympathetic neurons (unpublished
data) or by K
 
 
 
 deprivation in CGNs (Brunet et al., 1999;
Le-Niculescu et al., 1999), two macromolecular synthesis–
dependent models of neuronal PCD. Taken together, these
findings suggest that Fas–FasL interactions may contribute
to TFD-induced neuronal apoptosis in SCG and CG neu-
rons.
To evaluate the requirement for Fas signaling during
TFD-induced neuronal apoptosis, we examined survival af-
ter K
 
 
 
 or NGF withdrawal in CG and SCG neurons, re-
spectively, from 
 
lpr
 
 and 
 
gld
 
 mice, which harbor loss-of-func-
tion mutations in Fas and FasL, respectively. As shown in
Fig. 3 B, the 
 
lpr
 
 and 
 
gld
 
 mutations altered neither the extent
nor the kinetics of K
 
 
 
 deprivation–induced apoptosis in
CGNs, consistent with the findings of Gerhardt et al.
(2001). Similarly, the mutations did not prevent TFD-
induced apoptosis in sympathetic neurons (survival at 72 h
relative to NGF-maintained sister cultures: 
 
wt/wt
 
 
 
 
 
 2.74 
 
 
 
0.57%; 
 
lpr/lpr
 
 
 
 
 
 2.31 
 
 
 
 0.33%; 
 
gld/gld
 
 
 
 
 
 1.85 
 
 
 
 2.05%;
 
n
 
 
 
 
 
 3). Furthermore, activation of extrinsic pathway signal-
ing by TNF
 
 
 
, soluble FasL, or agonistic Fas antibody Jo-2
did not induce cell death in NGF-maintained sympathetic
(unpublished data) or K
 
 
 
-maintained CGNs (Gerhardt et al.,
2001). Finally, targeted deletion of 
 
Bid
 
, a critical target for
death receptor–mediated apoptosis, did not alter the time-
course or extent of cyt c release or cell death in either SCG
or CG neurons (see Fig. 5). Thus, although withdrawal of
survival factors induced expression of both Fas and FasL in
Figure 2. Subcellular distribution of pro- and antiapoptotic BCL-2 
family proteins during neuronal apoptosis. DIV5 SCG neurons 
were maintained in NGF or deprived of NGF in the presence of 50 
 M BAF for 30 h The subcellular localization of BCL-2 proteins was 
examined by fractionation with alkali extraction by using 0.2 M 
Na2CO3 (pH 11.5). SDS (1% wt/vol) served as a positive control for 
the extraction of integral membrane proteins. C, cytosol; HM, heavy 
membrane; 1, isotonic buffer; 2, 0.2 M Na2CO3; 3, 1% SDS). 
Lactate dehydrogenase and cytochrome oxidase subunit IV (COX IV) 
served as markers for the purity of cytosolic (C) and heavy membrane 
(HM) fractions, respectively, and as markers for equal protein loading. 
Markers for the endoplasmic reticulum and Golgi body labeled only 
the microsomal fraction (not depicted here). Please note that the 
BAX, BIM, and cyt c blots have been reported previously in Putcha 
et al. (2000, 2001) and are included only for comparison.Trophic factor deprivation-induced cell death signaling | Putcha et al. 445
SCG and CG neurons, extrinsic pathway signaling mediated
by Fas (and presumably by other death receptors) is not re-
quired for—and may not contribute to—neuronal apoptosis
in these particular paradigms.
Deletion of Bak, Bid, or Bad does not attenuate
TFD-induced neuronal apoptosis
Hepatocytes, embryonic fibroblasts, and some lympho-
cytes—and perhaps other mitotic nonneuronal cells—may
require both BAX and BAK for cyt c release and cell death in
response to certain intrinsic (e.g., TFD) or extrinsic (e.g.,
TNF/ActD) pathway stimuli (Lindsten et al., 2000; Wei et
al., 2001), suggesting that BAX and BAK are functionally
redundant, at least in a cell type– and stimulus-specific man-
ner. We examined the generality of such functional redun-
dancy by examining TFD-induced neuronal apoptosis in
Bax
 /  and Bak
 /  mice. As reported previously, Bax dele-
tion completely prevents cyt c release and PCD in NGF-
deprived SCG and K
 -deprived CG neurons (Fig. 1; Deck-
werth et al., 1996; Miller et al., 1997; Deshmukh and
Johnson, 1998; Putcha et al., 2000); in contrast, Bak dele-
tion did not alter the extent or kinetics of cyt c release or
apoptosis in either cell type (Fig. 4, A and B). Therefore, de-
spite coexpression (Fig. 1) and appropriate subcellular local-
Figure 3. TFD induces Fas and FasL 
expression in neurons, but inactivating 
mutations in Fas and FasL do not alter 
the kinetics of neuronal apoptosis. 
(A) DIV5 SCG neurons were deprived 
of NGF for the indicated times. RT-PCR 
analysis with primers specific for Fas and 
FasL was performed. Quantitation (relative 
to t   0 h) was performed by using 
ImageQuant (Molecular Dynamics). 
Similar results were obtained in an 
independent timecourse. (B) DIV7 CGNs 
from wild-type (C57BL/6), lpr, or gld mice 
were maintained in K25 S or K5 S for 
various periods. At the indicated times, 
cells were stained with the vital dye 
calcein AM and photographed. A naïve 
observer then counted the number of 
calcein AM–stained neurons in the photo-
micrographs. Mean   SEM, n   3.
Figure 4. Bak deletion does not alter the kinetics or extent of cyt c 
release or apoptosis in SCG or CG neurons. (A) DIV5 SCG neurons 
from Bak
 / , Bak
 /–, or Bak
–/– mice were maintained in NGF or 
deprived of NGF in the presence of 50  M BAF for various periods. 
At the indicated times, cells were fixed and immunostained for cyt 
c. Then, the number of cells exhibiting diffuse cytosolic cyt c was 
determined by a naïve observer. At all time points, NGF-maintained 
neurons showed punctate, mitochondrial cyt c. Mean   SEM, n   3–4. 
(B) DIV7 CGNs from Bak
 / , Bak
 /–, or Bak
–/– mice were maintained 
in K25 S or K5 S for various periods. At the indicated times, cells 
were stained with the vital dye calcein AM and lysed. The fluores-
cence of an aliquot of the lysate was then measured on a TiterTek 
fluorescence plate reader. Mean   SEM, n   3–4. (C) DIV5 CGNs 
from Bax
 /  or Bax
–/– mice were cotransfected with EGFP and the 
indicated vector. The number of GFP-positive cells was counted 48 h 
later and expressed as a percentage of vector (pcDNA3.1)-transfected 
cells. Mean   SD, n   2 in duplicate.446 The Journal of Cell Biology | Volume 157, Number 3, 2002
ization (Fig. 2; and unpublished data), BAX and BAK were
not functionally redundant in CG neurons.
To examine this issue of functional redundancy further,
we examined whether reintroduction of either Bax or Bak by
transient transfection could overcome the cell death defec-
tive phenotype conferred by Bax deletion in CGNs. As
shown in Fig. 4 C, overexpression of either Bax or Bak, but
not tBid, killed Bax
 /  CGNs. Thus, at least in CGNs, BAX
and BAK were not functionally redundant at physiological
levels of expression, but can be functionally equivalent when
overexpressed.
Although redundancy did not exist among multidomain
proapoptotic BCL-2 proteins in CGNs, such redundancy
may exist between BH3-only proteins in these same cells.
Specifically, reproduction of the Bax
 /  phenotype, in
which cyt c release and apoptosis are completely pre-
vented, may require inactivation of at least both Bim and
Hrk in these neurons (Putcha et al., 2001). However,
SCG and CG neurons also express at least two other
BH3-only proteins, namely BID and BAD, which have
been widely implicated in processes (e.g., BAX transloca-
tion and integration and BAX/BAK-dependent cyt c re-
lease) required for apoptosis in these particular cells.
Therefore, we examined whether targeted deletion of Bid
or Bad inhibited neuronal apoptosis in SCG and CG neu-
rons. As shown in Figs. 5 and 6, respectively, Bid or Bad
deficiency did not affect either the extent or kinetics of cyt
c release or apoptosis after NGF deprivation in SCG neu-
rons (Figs. 5 A and 6 A) or K
  withdrawal in CG neurons
(Fig. 5 B; and unpublished data). Thus, despite coexpres-
sion of multiple BH3-only proteins (i.e., BAD, BID,
BIM, and HRK), only BIM—and we predict HRK—reg-
ulated BAX-dependent cyt c release and neuronal apopto-
sis in SCG and CG neurons.
Inactivation of critical components of the intrinsic and 
extrinsic pathways does not inhibit posttranslational 
regulation of apoptosis by NGF
SCG neurons from Bak
 / , Bid
 / , or Bad
 /  mice and
from their wild-type and heterozygote littermates were de-
prived of NGF in the presence of BAF for 18 h; the pat-
tern of cyt c staining was assessed. In parallel cultures,
NGF was readded, and the pattern of cyt c staining was
determined 18 h later. As shown in Fig. 7, the gene dosage
of Bak, Bid, or Bad did not affect NGF-mediated acute ar-
rest of cyt c release, a measure of the ability of NGF to pre-
vent apoptosis posttranslationally. Taken together with
the results shown in Figs. 4–6, these findings suggest that,
in sympathetic neurons, BAK, BID, and BAD were not re-
quired for TFD-induced apoptosis and did not contribute
to the regulation of neuronal PCD by either transcrip-
tional or posttranslational mechanisms. Furthermore,
these proteins were not required for K
  withdrawal–
induced apoptosis in CGNs.
Figure 5. Bid deficiency does not alter the timecourse or extent 
of cyt c release or apoptosis in SCG or CG neurons. (A) DIV5 SCG 
neurons from Bid
 / , Bid
 /–, or Bid
–/– mice were maintained in NGF 
or deprived of NGF in the presence of 50  M BAF for various periods. 
At the indicated times, cells were fixed and immunostained for cyt 
c. Then, the number of cells exhibiting diffuse cytosolic cyt c was 
determined by a naïve observer. At all time points, NGF-maintained 
neurons showed punctate, mitochondrial cyt c. Mean   SEM, n   3–6. 
(B) DIV7 CGNs from Bid
 / , Bid
 /–, or Bid
–/– mice were maintained 
in K25 S or K5 S for various periods. At the indicated times, cells 
were stained with the vital dye calcein AM and lysed. The fluores-
cence was then measured on a TiterTek fluorescence plate reader. 
Mean   SEM, n   3–4. 
Figure 6. Bad deletion does not alter the kinetics or extent of cyt 
c release or apoptosis in SCG neurons. DIV5 SCG neurons from 
Bad
 / , Bad
 /–, or Bad
–/– mice were maintained in NGF or deprived 
of NGF in the presence of 50  M BAF for various periods. At the 
indicated times, cells were fixed and immunostained for cyt c. 
Then, the number of cells exhibiting diffuse cytosolic cyt c was 
determined by a naïve observer. At all time points, NGF-maintained 
neurons showed punctate, mitochondrial cyt c. Mean   SEM, n   3–4.Trophic factor deprivation-induced cell death signaling | Putcha et al. 447
Targeted deletion of Bax, Bak, Bim, Bid, or Bad does 
not cause compensatory changes in the expression of 
other BCL-2 family proteins
The findings described above indicate that at least some
multidomain and BH3-only BCL-2 proteins were not func-
tionally redundant, at least in SCG and CG neurons, despite
coexpression. To determine whether functional compensa-
tion by changes in the expression of other family members
might account for the absence of neuronal PCD defects in
NGF-deprived sympathetic neurons from Bak
 / , Bid
 / ,
and Bad
 /  mice, we examined expression of other BCL-2
proteins for which we had reliable reagents, in SCG neurons
from these mice and from their wild-type littermates. As
shown in Fig. 8, we did not observe any such compensatory
changes in the expression of pro- or antiapoptotic BCL-2
proteins. Furthermore, we did not observe such changes in
several other tissues (e.g., cortex, cerebellum, liver, and
spleen; unpublished data). Furthermore, TFD induced BIM
expression in Bax
 / , Bak
 / , Bid
 / , and Bad
 /  sympa-
thetic neurons (Fig. 8; and unpublished data). Finally, as
previously reported for SCG neurons from mice overex-
pressing Bcl-2 (Putcha et al., 1999) or lacking Bax (Deck-
werth et al., 1998) or Bim (Putcha et al., 2001), activation of
the JNK signaling pathway (as indicated by phosphorylation
of c-Jun), which is critical for apoptosis in this paradigm, oc-
curred normally in Bak
 / , Bid
 / , and Bad
 /  sympathetic
neurons (Fig. 8; and unpublished data).
Discussion
SCG and CG neurons expressed all antiapoptotic BCL-2
proteins examined, yet only expressed certain BH3-only and
multidomain proapoptotic BCL-2 family members. All co-
expressed proapoptotic proteins did not, however, exhibit
functional redundancy or compensatory expression, at least
in the Bax
 / , Bak
 / , Bim
 / , Bid
 / , and Bad
 /  neurons
examined here. For example, despite expression and appro-
priate subcellular localization, BAK was not functionally re-
dundant with BAX, at least in CG neurons. Similarly, tar-
geted deletion of Bim, but not Bid or Bad, attenuated these
processes, consistent with BIM sharing functional redun-
dancy with another BH3-only protein, presumably HRK,
but not BID or BAD. Furthermore, neither transcriptional
nor posttranslational mechanisms appeared to regulate the
expression or subcellular localization of BID, BAD, or BAK
in these paradigms. Finally, despite modest induction of Fas
and FasL expression, Fas-mediated signaling in particular—
and presumably extrinsic pathway signaling more gener-
ally—did not contribute to TFD-induced PCD in these
neurons.
Antiapoptotic BCL-2 proteins in neuronal apoptosis: an 
abundance of riches
Over a decade after the cloning of its founding member, the
BCL-2 family is still an enigma whose precise biochemical
mechanisms remain unclear. In the case of antiapoptotic
members, many questions remain: do they promote cell sur-
vival in vertebrates by regulating apoptosome activation
through direct protein–protein interactions as in C. elegans,
by regulating mitochondrial permeability or bioenergetics,
by other mechanisms, or some combination of all of the
above? If mitochondria are the focus of their actions, do an-
tiapoptotic BCL-2 proteins act solely by inactivating their
proapoptotic counterparts or do they possess intrinsic, sur-
vival-promoting properties? If so, does the hypothesized
“rheostat” (Oltvai and Korsmeyer, 1994) involve direct pro-
Figure 7. Inactivation of Bak, Bid, or Bad does not affect post-
translational regulation of neuronal apoptosis by NGF. DIV5 SCG 
neurons from Bak
 / , Bak
 /–, or Bak
–/– (A); Bid
 / , Bid
 /–, or Bid
–/– 
(B); or Bad
 / , Bad
 /–, or Bad
–/– (C) mice deprived of NGF in the 
presence of 50  M BAF for various periods. At the indicated times, 
cells were fixed and immunostained for cyt c. In parallel, neurons 
that were deprived of NGF in the presence of 50  M BAF for 18 h 
were washed and rescued with 300 ng/ml NGF and 50  M BAF. 
After an additional 18 h, these cells were fixed and immunostained 
for cyt c. Then, the number of cells exhibiting diffuse cytosolic cyt c 
was determined by a naïve observer. Mean   SEM; n   3–4 (A),
n   3–6 (B), and n   3–4 (C).448 The Journal of Cell Biology | Volume 157, Number 3, 2002
tein–protein interactions and what are the critical partners
in vivo? And finally, what are the functional forms of BAX,
BCL-2, and so forth—monomers, homodimers, homomul-
timers, heterodimers, heteromultimers, or some combina-
tion of all of these? Disparate answers to all these questions
exist in the literature.
TFD in SCG and CG neurons sheds light on some of
these questions. Both cell types express all antiapoptotic
BCL-2 proteins examined (Figs. 1 and 2; and unpublished
data). Like most proteins, total levels of BCL-2, BCL-XL,
and BCL-w remained essentially unchanged until relatively
late in the cell death process, after BAX translocation and cyt
c release (Fig. 1). However, subtle changes in the subcellular
distributions of these proteins were intriguing. For example,
BCL-2 was found as an integral membrane protein in the
heavy membrane and microsomal fractions, which include
mitochondria and ER, respectively, in both NGF-main-
tained and -deprived sympathetic neurons (Fig. 2; unpub-
lished data). In contrast, BCL-XL and especially BCL-w were
distributed more evenly between the cytosolic and mito-
chondrial compartments in NGF-maintained SCG neurons,
and TFD caused loss of the cytosolic pools of these proteins,
with relative sparing of the mitochondrial pools. Such selec-
tive degradation of cytosolic BCL-w and BCL-XL might fa-
cilitate the translocation of BAX to mitochondria. However,
a recent report on the tertiary structure of BAX suggests that
its BH3 domain, which is required for heterodimerization
with BCL-XL and BCL-w, may not be exposed for such in-
Figure 8. Deletion of Bax, Bak, Bim, Bid, or Bad does not cause compensatory changes in the expression 
of other BCL-2 family proteins. Sympathetic neurons (DIV5) from mice of the indicated genotypes were 
maintained in NGF or deprived of NGF in the presence of 50  M BAF for 24 h. Cells were then lysed 
and examined by immunoblotting.Trophic factor deprivation-induced cell death signaling | Putcha et al. 449
teractions (Suzuki et al., 2000). Taken together with other
observations that interactions between BAX and antiapop-
totic BCL-2 proteins expressed at endogenous levels may
not occur in the absence of conformation-altering detergents
(Hsu and Youle, 1997; Antonsson et al., 2001), these find-
ings cast doubt on the existence a physical BAX/BCL-w/
BCL-XL rheostat in the cytosol of these neurons. We do not
favor the hypotheses that cytosolic BCL-w and/or BCL-XL
functions as the anchor that prevents cytosolic BAX from
translocating to the mitochondria in NGF-maintained SCG
neurons, or that selective loss of these pools (e.g., by ubiqui-
tination and proteasomal degradation) is the trigger for BAX
translocation during apoptosis. Instead, as described else-
where (Harris and Johnson, 2001), we propose that BAX
exists in dynamic equilibrium in at least two subcellular
compartments (i.e., cytosol and mitochondria) and that
BH3-only proteins disrupt this equilibrium by inactivating
antiapoptotic BCL-2 proteins, thereby indirectly promoting
BAX translocation and its downstream sequelae (see Fig. 9).
Multidomain proapoptotic BCL-2 proteins in neuronal 
apoptosis: similar but not equal
A limitation of current gene targeting technologies (in mice)
is the difficulty interpreting the absence of a phenotype
when ablating the function of a single or even several mem-
bers of vertebrate multigene families as large as the BCL-2
( 21 members), caspase ( 14 members), and inhibitor-
of-apoptosis protein ( 6 members) families. Accordingly,
functional redundancy (Lindsten et al., 2000; Zheng et al.,
2000; Wei et al., 2001) or compensation (Harlin et al.,
2001) among members may explain why targeted deletion
of individual genes often produces little or no cell death phe-
notype, at least with certain paradigms. The mechanisms
underlying compensatory changes in expression, whereby
cells from knock-out mice cannot only sense diminished ex-
pression of one family member but can also up-regulate,
sometimes dramatically (Harlin et al., 2001), expression of
another functionally redundant member, are unclear. How-
ever, those mechanisms responsible for functional redun-
dancy among family members seem self-evident, namely
that similar proteins can function similarly. In the case of
the multidomain proapoptotic subfamily of BCL-2 proteins
consisting of BAX, BAK, and BOK, the hypothesis—sub-
stantiated by two recent reports (Lindsten et al., 2000; Wei
et al., 2001)—is that BAX and BAK are essentially inter-
changeable. Findings reported in this paper demonstrate
that this is not true in all cell types.
CG neurons express both BAX and BAK, but not BOK
(Figs. 1 and 2, and unpublished data). However, Bax dele-
tion alone confers complete, long-term protection (Miller et
al., 1997), whereas Bak deficiency did not change either the
kinetics or extent of apoptosis (Fig. 4). Moreover, inhibition
of cell death by Bax deletion can be overcome by reintroduc-
tion of either Bax or Bak (but not tBid) by transient transfec-
tion (Fig. 4 C). Finally, targeted deletion of either did not
cause compensatory changes in the expression (Fig. 8) or
subcellular localization (unpublished data) of the other.
Thus, at physiological levels of expression, BAX and BAK
may not always be functionally redundant; however, when
overexpressed, they can be.
BH3-only proapoptotic BCL-2 proteins in neuronal 
apoptosis: functional redundancy and implications for 
BAX-dependent cyt c release
Emerging within the BCL-2 family of proteins is a subfam-
ily of proapoptotic molecules that share homology only
within the BH3 domain. When overexpressed, many of
these “BH3-only” proteins (e.g., BIM and HRK), like their
multidomain cousins, localize to mitochondria, cause cyt c
release, and induce cell death that can be attenuated by cas-
pase inhibition or cooverexpression of antiapoptotic BCL-2
proteins (Imaizumi et al., 1997; Inohara et al., 1997;
O’Connor et al., 1998).
Recently, we reported that TFD significantly induces ex-
pression of the BH3-only protein BIM in multiple neuronal
populations (in vivo and in vitro), including SCG, DRG,
and CG neurons (Putcha et al., 2001). In both sympathetic
and CGNs, induction of BIM (Putcha et al., 2001) and
HRK (Harris and Johnson, 2001) occurs upstream of (or in
parallel with) the BAX/BCL-2 and caspase checkpoints.
Moreover, in CG neurons, cell death caused by ectopic over-
expression of BH3-only proteins (e.g., BID, BIM, or HRK)
requires BAX (Fig. 4 C; Harris and Johnson, 2001). Finally,
Bim deletion delayed, but did not prevent, cyt c release and
apoptosis in SCG and CG neurons, suggesting that BIM
shared functional redundancy with other BH3-only proteins
(e.g., HRK).
Both SCG and CG neurons expressed a limited repertoire
of BH3-only proteins, including BAD, BID, BIM, and
HRK (Figs. 1 and 2; and unpublished data). Since Hrk
 / 
mice are not yet available, we examined whether BAD or
BID was responsible for this redundancy. Analysis of cells
from Bid
 /  and Bad
 /  mice indicated that neither BID
nor BAD contributed to neuronal apoptosis in NGF-
deprived SCG or K
 -deprived CG neurons. Furthermore,
neither transcriptional nor posttranslational mechanisms ap-
peared to regulate BID or BAD in these paradigms (Figs. 1
and 2).
To our knowledge, TFD in SCG and CG neurons is the
only primary cell culture paradigm entirely dependent on
the expression and translocation of BAX alone for cyt c re-
lease, caspase activation, and apoptosis (Deckwerth et al.,
1996; Miller et al., 1997; Deshmukh and Johnson, 1998;
McGinnis et al., 1999; Putcha et al., 1999, 2000), although
this may also be true for other neuronal populations (Deck-
werth et al., 1996; Li et al., 2001). Therefore, these models
are excellent for studying the physiological mechanisms
responsible for endogenous BAX translocation and BAX-
dependent cyt c release. Moreover, macromolecular synthe-
sis is required for BAX translocation, cyt c release, and apop-
tosis during TFD in SCG neurons (Martin et al., 1988;
Deckwerth et al., 1996; Deshmukh and Johnson, 1998;
Neame et al., 1998; Putcha et al., 1999), and the BH3-only
proteins BIM and HRK are induced in cells destined to die
and require BAX to mediate cell death (Imaizumi et al.,
1997; Harris and Johnson, 2001; Putcha et al., 2001; Whit-
field et al., 2001). Taken together, these findings clearly sug-
gest that BH3-only proteins may mediate BAX translocation
and its downstream sequelae. However, our results are con-
sistent with several possibilities, which need not be mutually
exclusive, for how this may occur (Fig. 9 A).450 The Journal of Cell Biology | Volume 157, Number 3, 2002
First (model 1), BH3-only proteins may interact directly
with BAX in the cytosol to trigger its translocation to mito-
chondria, where it integrates and mediates the release of ap-
optogenic intermembrane-space proteins, such as cyt c. Al-
ternatively (model 2), BH3-only proteins may interact
directly with BAX at mitochondria to form a multiprotein
complex that mediates cyt c release. We do not favor these
models for several reasons. First, the tertiary structure of sol-
uble, cytosolic BAX seems inconsistent with BAX interact-
ing with BH3-only proteins in the cytosol, arguing against
model 1. Specifically, the BH1 and BH2 domains, which
presumably would mediate interactions with a “BH3 do-
nor,” are not accessible for such interactions (Suzuki et al.,
2000). (Whether the “BH3-binding pocket” formed by
BH1 and BH2 becomes accessible upon integration into the
outer mitochondrial membrane by BAX or BAK is unclear.)
Second, to date, only three known or putative BH3-only
proteins may be cytosolic: BID, BAD, and MAP-1. Al-
though the physiological role of MAP-1 is unknown, dele-
tion of neither BID nor BAD altered the timecourse or ex-
tent of TFD-induced cyt c release or apoptosis in SCG or
CG neurons, arguing against model 1 for these proteins
(Figs. 5 and 6; and unpublished data). Therefore, neither
tBID, BID, nor BAD appear to be the cytosolic triggers for
BAX translocation and its downstream sequelae in SCG and
CG neurons. Finally, deletion of Bim (and presumably Hrk)
attenuates BAX-dependent cyt c release (Putcha et al.,
2001). However, neither protein appears to be cytosolic (In-
ohara et al., 1997; Putcha et al., 2001), which argues against
model 1, or can interact directly with BAX (Inohara et al.,
1997; O’Connor et al., 1998), which argues against models
1 and 2.
Next, BH3-only proteins may indirectly promote BAX-
dependent cyt c release by interacting with and inactivating
antiapoptotic BCL-2 proteins, either in the cytosol (model 3)
or at mitochondria (model 4), thereby freeing BAX to mul-
timerize and integrate, forming structures that release cyt c. Both
models are generally consistent with the genetics and bio-
chemistry of PCD in C. elegans in which a BH3-only protein
(i.e., EGL-1 in worms, BIM and HRK in vertebrate neurons)
is induced in cells destined to die and interacts with and inac-
tivates an antiapoptotic BCL-2 protein, leading to apopto-
some formation, caspase activation, and apoptosis. (A caveat,
of course, concerns the requirement for cyt c release in verte-
brates, but not in worms.) However, we favor model 4 for sev-
eral reasons. First, antiapoptotic BCL-2 proteins may not
interact directly with BAX in the cytosol, except in the pres-
ence of conformation-altering nonionic detergents (Hsu and
Youle, 1997; Antonsson et al., 2001), which may mimic a
membrane environment, arguing against model 3, but for
model 4. Second, the tertiary structure of BAX may be incon-
sistent with interactions with antiapoptotic BCL-2 proteins in
the cytosol (Suzuki et al., 2000), which argues against model
3, but not model 4. Third, BIM and HRK, two BH3-only
proteins that we propose are critical for TFD-induced apopto-
sis in neurons, do not interact directly with BAX and appear
to localize to mitochondria. Moreover, the proapoptotic ac-
tivity of these proteins generally correlates with their ability
to interact with, and inactivate, their antiapoptotic cousins
(Wang et al., 1996; Inohara et al., 1997; O’Connor et al.,
1998). Finally, this hypothesis may help explain a “threshold
effect” observed with both BIM and HRK. Specifically, neu-
rons can tolerate a certain level of BIM and HRK induction
without releasing cyt c or undergoing cell death (Harris and
Johnson, 2001; Putcha et al., 2001). For example, during
TFD in Bcl-2-overexpressing SCG and CG neurons, BIM
levels increase with time (to a point greater than that seen in
wild-type littermates) and then decline precipitously as cells
begin to die; in contrast, in Bax
 /  neurons, BIM levels con-
tinue to increase (to levels exceeding even those seen in Bcl-2-
overexpressing cells) and only begin to decline days later when
significant decreases in global macromolecular synthesis begin
to dismantle the synthetic machinery needed to sustain the in-
duction. Accordingly, overexpression of Bcl-2 only attenuates
TFD-induced cyt c release and apoptosis in SCG and CG
Figure 9. BH3-only proteins indirectly trigger BAX translocation, 
cyt c release, caspase activation, and apoptosis during TFD-induced 
neuronal cell death. (A) Shown are four proposed models depicting 
how BH3-only proteins, such as BIM and HRK, may promote BAX 
translocation and its downstream sequelae during TFD in SCG and 
CG neurons. Models 1 and 2 invoke direct interaction of BH3 
donors with BAX, whereas models 3 and 4 involve BH3-only proteins 
indirectly triggering BAX translocation via inactivating interactions 
with antiapoptotic BCL-2 proteins. We favor model 4 for reasons 
discussed in the text. (B) A dynamic equilibrium model for BAX 
translocation. During TFD in SCG and CG neurons, BIM and HRK 
are induced and inactivate antiapoptotic BCL-2 proteins, thereby 
altering the equilibrium between cytosolic and mitochondrial pools 
of BAX, culminating in apparent BAX translocation, multimerization, 
and integration, followed by cyt c release, caspase activation, and 
apoptotic cell death. See text for more details.Trophic factor deprivation-induced cell death signaling | Putcha et al. 451
neurons (Tanabe et al., 1998; Putcha et al., 1999), whereas
Bax deletion completely prevents both (Figs. 1 and 4; Deck-
werth et al., 1996; Miller et al., 1997; Deshmukh and
Johnson, 1998; Putcha et al., 2000). The same is true for
CGN death caused by ectopic overexpression of BH3-only
proteins (Fig. 4 C; Harris and Johnson, 2001).
Therefore, we propose that cellular BAX exists in equilib-
rium between two states (Fig. 9 B), soluble in the cytosol or
peripherally associated with mitochondria, in NGF-main-
tained sympathetic neurons. With TFD, BH3-only proteins
are induced and localize to the outer mitochondrial mem-
brane, where they interact with and inactivate antiapoptotic
BCL-2 proteins, thereby allowing BAX peripherally associated
with mitochondria or translocated from the cytosol to multi-
merize and integrate. This creates a thermodynamic “sink”
that shifts the BAX equilibrium strongly (and perhaps irrevers-
ibly) in favor of mitochondrial localization, resulting in further
translocation and integration into the mitochondrial outer
membrane. In this scenario, inhibitors of de novo protein syn-
thesis should prevent BAX translocation (consistent with our
earlier findings [Putcha et al., 1999]) by preventing induction
of BH3-only proteins (Putcha et al., 2001). However, the
macromolecular synthesis dependence of BAX translocation in
this paradigm also has two possible interpretations that may
prove indistinguishable by approaches such as immunocy-
tochemistry and subcellular fractionation. First, BH3-only
proteins may directly cause BAX translocation, a possibility we
do not favor for reasons alluded to above. Second, BH3-only
proteins may indirectly promote BAX translocation by inhibit-
ing the inhibitors (i.e., antiapoptotic BCL-2 proteins). If true,
this second hypothesis predicts that ectopic overexpression of
BH3-only proteins (e.g., BIM, HRK, BID, or tBID) or multi-
domain proapoptotic proteins (e.g., BAX TM or BAK TM)
should induce BAX translocation and BAX-dependent cyt c
release, caspase activation, and apoptosis with appropriate ki-
netics in cells that require BAX for these processes. Although
incomplete, the available data is consistent with this prediction
(Harris and Johnson, 2001; Wei et al., 2001; Zong et al.,
2001). Therefore, we suggest that BH3-only proteins are trig-
gers, albeit indirect, for BAX translocation and its downstream
sequelae during TFD-induced neuronal apoptosis.
Materials and methods
Reagents
All reagents were purchased from Sigma-Aldrich unless otherwise stated.
Other reagents and their sources were collagenase and trypsin (Worthing-
ton Biochemical); caspase inhibitor boc-aspartyl(OMe)-fluoromethylke-
tone (BAF) (Enzyme Systems Products). Medium lacking NGF (AM0) con-
sisted of Eagle’s MEM with Earle’s salts (Life Technologies) supplemented
with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin, 100
 g/ml streptomycin, 20  M fluorodeoxyuridine, 20  M uridine, and 3.3
 g/ml aphidicolin. AM50 medium consisted of AM0 medium plus 50 ng/
ml mouse 2.5S NGF (Harlan Bioproducts). For CGNs, two different media
were used: K5 S (basal medium Eagle’s [Life Technologies] containing
10% dialyzed fetal bovine serum, 5 mM KCl, 100 U/ml penicillin, and 100
 g/ml streptomycin) and K25 S (K5 S plus 20 mM KCl). The breeding
and genotyping of Bax
 / , Bak
 / , Bad
 / , Bid
 / , and Bim
 /  mice have
been described previously (Knudson et al., 1995; Bouillet et al., 1999; Yin
et al., 1999; Lindsten et al., 2000).
Sympathetic neuronal cultures
Primary cultures of sympathetic neurons were established from the SCG of
neonatal mice or rats by using previously described methods (Johnson and
Argiro, 1983; Deckwerth et al., 1996). Neurons were grown in AM50 for
 5 d in vitro (DIV) and then either maintained in AM50 or treated as fol-
lows: For NGF deprivation, cultures were rinsed with AM0, followed by
the addition of AM0 containing goat anti-mouse 2.5S NGF neutralizing an-
tiserum (anti-NGF) (Ruit et al., 1990). For NGF deprivation in the presence
of BAF, 50  M BAF was added to AM0 containing anti-NGF.
CGN cultures
Primary cultures of CGNs were obtained as described previously (Miller
and Johnson, 1996; Miller et al., 1997). Briefly, postnatal day 7 (P7) cere-
bella were dissected, trypsinized, triturated, and plated into K25 S me-
dium at a density of 2.3   10
5 cells/cm
2 in four-well dishes (Nunc) coated
with 0.1 mg/ml poly-L-lysine. To reduce the number of nonneuronal cells,
3.3  g/ml aphidicolin was added to the medium 36 h after plating. At
DIV7, CGNs were either maintained in K25 S or switched to K5 S after
washing once with the respective medium. Cell viability was then assessed
at the indicated times by taking photomicrographs of representative fields
of cells labeled with calcein AM (Molecular Probes) as described previ-
ously (Miller and Johnson, 1996). Alternatively, viability was assessed by
lysing the calcein AM-stained cells and measuring the fluorescence on a
TiterTek fluorescence plate reader (emission   485/excitation   538).
RT-PCR analysis, CGN transfection, subcellular fractionation, 
alkali extraction, and immunoblotting
RT-PCR analysis, CGN transfection, fractionation, extraction, and immu-
noblotting of sympathetic neurons were performed as described previously
(Estus et al., 1994; Putcha et al., 2000). Primary antibodies included  -tubu-
lin (1:100000; Sigma-Aldrich); Bad (C-20; 1:200; Santa Cruz Biotechnol-
ogy, Inc.); Bak (1:1000; Upstate Biotechnology); Bax (1:1000; Upstate Bio-
technology); Bid (1:1000; Zymed or 1:1000; R&D Systems); Bim/Bod
(1:1000; StressGen); Bcl-2 (10C4; 1:500; NeoMarkers); Bcl-XL (H-9;
1:1000; Santa Cruz Biotechnology, Inc.); cyt c (1:1000; BD PharMingen);
cytochrome oxidase subunit IV (COX4) (Molecular Probes); lactate dehy-
drogenase (1:1000; Rockland Immunochemicals); neuron-specific enolase
(1:1000; Chemicon); phospho–c-Jun S63 (P-Jun) (1:1000; New England
Biolabs, Inc.). Bcl-w antibodies were provided by L.A. O’Reilly and S.
Cory (Walter and Eliza Hall Institute, Melbourne, Australia). Appropriate
HRP-conjugated secondary antibodies (NEB and Jackson ImmunoResearch
Laboratories) were diluted 1:5000–1:10000.
All antibodies (except those for Bcl-2, Bcl-w, and Bcl-XL that had been
tested in other contexts) were tested for specificity by immunoblotting with
tissues (e.g., spleen, thymus, liver, kidney, cortex, and cerebellum) from
knockout mice. In our experience, many antibodies to Bcl-2 family pro-
teins are not specific by this criterion. Even fewer are specific by immuno-
cytochemistry. Although we have found several examples of antibodies
that are specific by Western but are not specific by immunocytochemistry,
the converse has never been true. A listing of the antibodies for which we
have results is available online at http://www.jcb.org/cgi/content/full/
jcb.200110108/DC1.
Cell counts: commitment point experiments
Sympathetic neurons from mice of the indicated genotypes were deprived
of NGF as described above. At various times after deprivation, cultures
were rinsed with AM0 and then incubated in AM50 for 5 7 d. Neurons
were then counted after washing with PBS, fixing with 4% paraformalde-
hyde for 30 min at 4 C, washing again with PBS, and staining with tolui-
dine blue as described previously (Deshmukh et al., 1996).
Cell counts: P-Jun and Cyt c immunocytochemistry
Neuronal cultures were immunostained as described previously (Putcha et
al., 1999). Briefly, sympathetic neurons that had been maintained in NGF
for  5 DIV in AM50 were deprived of NGF in the presence of the caspase
inhibitor BAF (as described above). At various times after deprivation, cul-
tures were fixed and immunostained with anti–P-Jun (1:200; NEB) or anti–
cyt c (1:1000; BD PharMingen) antibodies. The respective secondary anti-
bodies were Cy3-conjugated donkey anti–rabbit and anti–mouse IgG (1.5
mg/ml; Jackson ImmunoResearch Laboratories), respectively, diluted 1:400.
For each time point, the number of cells that had acquired a nuclear stain-
ing pattern for P-Jun or had lost the punctate staining pattern for cyt c was
determined by a naïve observer from a random sampling of 100–200 cells.
All experiments were conducted in the presence of BAF to prevent any cell
loss that would otherwise affect the counts.
For acute rescue experiments in which NGF was readded to cultures af-
ter 18 h of NGF deprivation, cultures were rinsed with AM0 and then incu-
bated in AM0 medium containing 300 ng/ml NGF in the presence of 50
 M BAF.452 The Journal of Cell Biology | Volume 157, Number 3, 2002
Online supplemental material
Online supplemental Figs. S1–S4 show representative immunoblots of var-
ious commercially available antibodies to BAX (Fig. S1), BAK (Fig. S2),
BIM (Fig. S3), and BID (Fig. S4) tested in tissues from the respective knock-
out mice and their wild-type littermates. Similar experiments were per-
formed for antibodies to other cell death–related proteins (e.g., Apaf-1,
caspases, and other BCL-2 family proteins). In addition, immunocy-
tochemistry experiments were conducted in SCG and/or CG neurons with
certain antibodies. We occasionally did not evaluate antibodies that
proved nonspecific by immunoblotting for immunocytochemistry because,
in our experience, although some antibodies are specific by immunoblot-
ting but not by immunocytochemistry, the converse has never been true.
(That is, every antibody that is nonspecific by immunoblotting is also non-
specific by immunocytochemistry.) All results are tabulated in Table S1.
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